Advertisement

Pharmaceutisch Weekblad

, Volume 13, Issue 3, pp 127–129 | Cite as

Immunomodulation by quinones

A model for the use of quinones in the treatment of inflammation
  • L. A. 'T Hart
Reviews

Abstract

The therapeutic application of quinones in areas other than oncology, such as in chronic inflammation, has been proposed. However, because of the adverse side-effects on the function and vitality of almost all investigated cell types the therapeutical margin is small. The thiol-conjugating capacity of quinones may, however, be applied to reduce the tissue-damaging effects of stimulated neutrophils. In this paper evidence is provided that particular phenols may be used as precursor molecules of quinones. Secretory products from stimulated neutrophils can convert such phenols into quinones. As under normal conditions stimulated neutrophils are present only in inflamed tissues, quinones will be formed only at these sites.

Keywords

Immunomodulation Inflammation Quinones 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Van der Nat JM, Beijnen JH, Driebergen RJ, et al.In vitro immunosuppressive activities of recently developed anthracycline cytostatics. Anticancer Res 1988;8:489–4.PubMedGoogle Scholar
  2. 2.
    Gallin JI, Seligmann BE, Cramer EB, Schiffmann E, Fletcher MP. Effects of vitamin K on human neutrophil function. J Immunol 1982;128:1399–408.PubMedGoogle Scholar
  3. 3.
    Koster AS. Bioreductive activation of quinones: a mixed blessing. Pharm Weekbl [Sci] 1991;13(3):123–6.Google Scholar
  4. 4.
    D'Arcy Doherty M, Rodgers A, Cohen CM. Mechanisms of toxicity of 2- and 5-hydroxy-1,4-naphthoquin-one. Absence of a role of redox-cycling in the toxicity of 2-hydroxy-1,4-naphthoquinone to isolated hepatocytes. J Appl Toxicol 1987;7:123–9.PubMedGoogle Scholar
  5. 5.
    'T Hart LA, Van der Wal NAA, Koster ASj, Labadie RP. A rapid and sensitive microassay to determine the capacity of quinones to undergo redox-cycling. Toxicol Lett 1989;48:151–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Eastmond DA, French RC, Ross D, Smith MT. Metabolic activation of 1-naphthol and phenol by a simple superoxide-generating system and human leukocytes. Chem Biol Interactions 1987;63:47–52.CrossRefGoogle Scholar
  7. 7.
    'T Hart LA, Simons JM, Rijkers GT, Hoogvliet JC, Van Dijk H, Labadie RP. Reaction products of 1-naphthol with reactive oxygen species prevent NADPH oxidase activation in activated human neutrophils, but leave phagocytosis intact. Free Radical Biol Med 1990;8:241–9.CrossRefGoogle Scholar
  8. 8.
    Akard LP, English D, Gabig TG. Rapid deactivation of NADPH oxidase in neutrophils: continuous replacement of newly activated enzyme sustains the respiratory burst. Blood 1988;72:322–7.PubMedGoogle Scholar
  9. 9.
    Babior BM. Protein phosphorylation and the respiratory burst. Arch Biochem Biophys 1988;264:361–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Simons JM, 'T Hart LA, Ip Vai Ching TRAM, Van Dijk H, Labadie RP. Metabolic activation of natural phenols into selective oxidative burst antagonists by activated human neutrophils. Free Radical Biol Med 1990;8:251–8.CrossRefGoogle Scholar
  11. 11.
    'T Hart BA, Simons JM, Knaan-Shanzer S, Bakker NPM, Labadie RP. Anti-arthritic activity of the newly developed oxidative burst antagonist apocynin. Free Radical Biol Med 1990;9:127–31.CrossRefGoogle Scholar
  12. 12.
    Redegeld FAM, Moison RMW, Koster ASj, Noordhoek J. Alterations in energy status by menadione metabolism in hepatocytes isolated from fasted and fed rats. Arch Biochem Biophys 1989;273:215–22.CrossRefPubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1991

Authors and Affiliations

  • L. A. 'T Hart
    • 1
  1. 1.Department of Chronic and Infectious DiseasesInstitute for Applied Radiobiology and Immunology-TNOHV Rijswijkthe Netherlands

Personalised recommendations